JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on July 30, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/31/32913    most recent
M314098200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sierra, O. L.
Right arrow Articles by Towler, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sierra, O. L.
Right arrow Articles by Towler, D. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print May 6, 2004
J. Biol. Chem, 10.1074/jbc.M314098200
Submitted on December 23, 2003
Revised on April 15, 2004
Accepted on May 6, 2004

MINT, the Msx2 interacting nuclear matrix target, enhances runx2 - dependent activation of the osteocalcin fibroblast growth factor response element

Oscar L. Sierra, Su-Li Cheng, Arleen P. Loewy, Nichole Charlton-Kachigian, and Dwight A. Towler

Internal Medicine, Division of Bone and Mineral Diseases, Washington University Medical Center, St. Louis, MO 63110

Corresponding Author: dtowler{at}im.wustl.edu

Msx2 promotes osteogenic lineage allocation from mesenchymal progenitors, but inhibits terminal differentiation demarcated by osteocalcin (OC) gene expression. Msx2 inhibits OC expression by targeting the Fibroblast Growth Factor responsive element (OCFRE), a 42 bp DNA domain in the OC gene bound by MINT and Runx2/Cbfa1. To better understand Msx2 regulation of the OCFRE, we have studied functional interactions between MINT -- the Msx2 interacting nuclear target protein – and Runx2, a master regulator of osteoblast differentiation. In MC3T3E1 osteoblasts (with endogenous Runx2 and FGFR2), MINT augments transcription driven by the OCFRE that is further enhanced by FGF2 treatment. OCFRE regulation can be reconstituted in the naïve CV1 fibroblast cell background. In CV1 cells, MINT synergizes with Runx2 to enhance OCFRE activity in the presence of activated FGFR2. The RRM domain of MINT (binds the OCFRE) is required. Runx2 structural studies reveal that synergy with MINT uniquely requires Runx2 Activation Domain 3 (AD3). In confocal immunofluorescence microscopy, MINT adopts a reticular nuclear matrix distribution that overlaps transcriptionally active osteoblast chromatin, extensively co-localizing with the phosphorylated RNA polymerase II (RNAP IIo) meshwork. MINT only partially co-localizes with Runx2; however, co-localization is enhanced 2.5-fold by FGF2 stimulation. Msx2 abrogates Runx2-MINT OCFRE activation, and MINT-directed RNA interference reduces endogenous OC expression. In chromatin immunoprecipitation assays, Msx2 selectively inhibits Runx2 binding to OC chromatin. Thus, MINT enhances Runx2 activation of multiprotein complexes assembled by the OCFRE. Msx2 targets this complex as a mechanism of transcriptional inhibition. In osteoblasts, MINT may serve as a nuclear matrix platform that organizes and integrates osteogenic transcriptional responses.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S.-L. Cheng, J.-S. Shao, J. Cai, O. L. Sierra, and D. A. Towler
Msx2 Exerts Bone Anabolism via Canonical Wnt Signaling
J. Biol. Chem., July 18, 2008; 283(29): 20505 - 20522.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Ma, M. J. Renda, L. Wang, E.-c. Cheng, C. Niu, S. W. Morris, A. S. Chi, and D. S. Krause
Rbm15 Modulates Notch-Induced Transcriptional Activation and Affects Myeloid Differentiation
Mol. Cell. Biol., April 15, 2007; 27(8): 3056 - 3064.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Feng, G. T. Bommer, Y. Zhai, A. Akyol, T. Hinoi, I. Winer, H. V. Lin, K. M. Cadigan, K. R. Cho, and E. R. Fearon
Drosophila split ends Homologue SHARP Functions as a Positive Regulator of Wnt/{beta}-Catenin/T-Cell Factor Signaling in Neoplastic Transformation
Cancer Res., January 15, 2007; 67(2): 482 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Yang, J. Li, H. Qin, H. Yang, J. Li, P. Zhou, Y. Liang, and H. Han
Mint Represses Transactivation of the Type II Collagen Gene Enhancer through Interaction with {alpha}A-crystallin-binding Protein 1
J. Biol. Chem., May 13, 2005; 280(19): 18710 - 18716.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.